T
Telomir Pharmaceuticals Inc
NASDAQ:TELO
Telomir Pharmaceuticals Inc
NASDAQ:TELO
Price:
1.25
USD
-0.79%
Market Closed
Market Cap:
$43m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Telomir Pharmaceuticals Inc
NASDAQ:TELO
|
US |
|
Peab AB
STO:PEAB B
|
SE |
|
American Bio Medica Corp
OTC:ABMC
|
US |
|
D
|
Dekuple
XBER:DLU
|
FR |
|
YSX Tech Co Ltd
NASDAQ:YSXT
|
CN |
|
J
|
JFB Construction Holdings
NASDAQ:JFB
|
US |
|
O
|
Ossur hf
CSE:OSSR
|
IS |
Balance Sheet
Balance Sheet Decomposition
Telomir Pharmaceuticals Inc
Telomir Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Telomir Pharmaceuticals Inc
Telomir Pharmaceuticals Inc
Balance Sheet
Telomir Pharmaceuticals Inc
Telomir Pharmaceuticals Inc
Currency: USD
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
7
|
|
| Cash |
0
|
0
|
0
|
1
|
7
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
7
|
|
| Other Long-Term Assets |
0
|
0
|
4
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
5
+9 702%
|
1
-72%
|
7
+454%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+614%
|
1
+35%
|
1
-49%
|
1
+110%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
1
|
14
|
31
|
41
|
|
| Additional Paid In Capital |
0
|
0
|
18
|
31
|
47
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
-579%
|
3
N/A
|
1
-81%
|
6
+820%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
5
+9 702%
|
1
-72%
|
7
+454%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
30
|
30
|
29
|
30
|
34
|
|
Switch to:
Switch to:
See Also
Discover More
